Skip to main content
BSF ENTERPRISE PLC logo

BSF ENTERPRISE PLC — Investor Relations & Filings

Ticker · BSFA ISIN · GB00BHNBDQ51 LEI · 2138007PJT69H8FYLC06 IL Professional, scientific and technical activities
Open in API
Filings indexed 171 across all filing types
Latest filing 2022-05-16 AGM Information
Country GB United Kingdom
Listing IL BSFA

About BSF ENTERPRISE PLC

https://bsfenterprise.com/

BSF Enterprise PLC is a biotechnology company that develops and commercializes cell-based, tissue-engineered solutions. The company focuses on creating innovative materials and products for various applications, including cultivated meat, lab-grown leather, and technologies for corneal repair. The core business model involves acquiring and advancing proprietary technologies in cellular agriculture and regenerative medicine with the objective of licensing its intellectual property.

Recent filings

Filing Released Lang Actions
Results of General Meeting
AGM Information Classification · 99% confidence The document is an official announcement released via RNS (Regulatory Information Service) on May 16, 2022. The core content reports the 'Results of General Meeting' where all proposed resolutions were duly passed by shareholders via a poll. It details the allotment of new shares (Consideration, Placing, and Restricted Shares) contingent on their admission to the London Stock Exchange. The key subject is the outcome of a shareholder vote and subsequent capital structure change resulting from that vote. This directly relates to the outcome of a general meeting and the declaration of voting results. While it involves share allotment (CAP/SHA), the primary focus and structure of the announcement is reporting the voting outcome. The category 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for reporting the results of a General Meeting poll. It is not a full AGM presentation (AGM-R) or a general capital change announcement (CAP/SHA) but specifically the results of the vote.
2022-05-16 English
BSF Enterprise Plc - Single prospectus
Regulatory Filings Classification · 97% confidence The document explicitly identifies itself as a "prospectus" relating to BSF Enterprise plc, prepared in accordance with the Prospectus Regulation Rules of the FCA. It details the admission of shares to the Official List and trading on the London Stock Exchange following an acquisition (a reverse takeover). A prospectus is a formal legal document required for offering securities to the public or seeking admission to trading on a regulated market. This aligns perfectly with the definition of a document related to capital raising or listing, which often falls under the scope of a Prospectus or a similar offering document. Given the options, while 'CAP' (Capital/Financing Update) is related, the document's structure, length, and explicit reference to 'Prospectus' and 'Admission' strongly suggest a primary offering/listing document. In many classification schemes, a Prospectus related to a listing or major financing event is often categorized separately or as a specific type of offering document. Since there is no explicit 'PROSPECTUS' code, I must choose the closest fit. A Prospectus is fundamentally about raising capital and listing shares. 'CAP' (Capital/Financing Update) is the closest category for a document detailing share issues, placing, and admission to the market, although 'DEF 14A' (Proxy/Information Statement) or 'RPA' (Report Publication Announcement) are incorrect as this is the primary document, not an announcement of it. However, the document is a comprehensive legal offering document, not just a brief update. Given the context of UK regulation (FCA, Listing Rules, Prospectus Regulation), this document is a formal offering document. If a specific Prospectus code is unavailable, 'CAP' is the most relevant category covering major financing/share issuance activities described herein (Placing, Issue of Shares, Admission). I will assign a high confidence score due to the explicit nature of the document content, even if the code is an approximation of a full Prospectus filing.
2022-04-29 English
Circular and Notice of General Meeting
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled 'CIRCULAR' and contains a 'NOTICE OF GENERAL MEETING' scheduled for May 16, 2022. It details a 'Proposed Acquisition,' a 'Proposed Waiver of Rule 9 of the Takeover Code,' a 'Placing of... Ordinary Shares,' and the 'Issue of... Consideration Shares.' It explicitly asks shareholders to vote on resolutions and provides a 'Form of Proxy' and instructions on how to vote. This structure—a detailed document sent to shareholders soliciting their vote for a significant corporate action (like an acquisition or waiver of a takeover rule) at a General Meeting—is characteristic of a Proxy Solicitation and Information Statement, often referred to as a Scheme Document or Circular in UK contexts, which aligns best with the definition of Proxy Solicitation & Information Statement (PSI). It is not a standard Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is a comprehensive document detailing the proposal and requesting a vote, PSI is the most accurate classification, although it also contains elements that might be found in an M&A document (TAR), the primary purpose here is shareholder approval via a meeting.
2022-04-28 English
Prospectus dated 27 April 2022
Capital/Financing Update Classification · 95% confidence The document explicitly identifies itself as a "prospectus" for the purposes of Article 3 of the UK version of Regulation (EU) 2017/1129, which has been approved by the FCA. It details the terms of a Placing, the issue of new shares, and the admission of shares to the London Stock Exchange following a reverse takeover. A prospectus is a key document required for offering securities to the public or seeking admission to trading on a regulated market. This aligns most closely with the requirements for a document related to capital raising or listing, which falls under the scope of a comprehensive offering document. While it contains financial information (Parts VIII, IX, X), its primary function as a legally mandated document for a public offering/listing makes it distinct from a standard 'Capital/Financing Update' (CAP) or a simple 'Interim Report' (IR). Given the options, a Prospectus related to a listing/offering is best categorized as a document detailing capital structure changes and public offering terms. However, none of the codes perfectly match 'Prospectus'. The document details the 'Placing of... Ordinary Shares' and 'Admission to the Official List'. This strongly suggests a document related to raising capital and listing. 'CAP' (Capital/Financing Update) is the closest fit for a document detailing a share placing and admission, although 'Prospectus' is a specific type of offering document. Since the document is a full, comprehensive legal document detailing the offering, it is more substantial than a simple 'CAP' announcement. Given the context of a major corporate action involving share issuance and listing approval by the FCA, it is a primary offering document. In many classification schemes, a Prospectus is often grouped with major financing activities. I will classify it as 'CAP' (Capital/Financing Update) as it details the placing and admission, which are core financing activities, while acknowledging it is a Prospectus.
2022-04-28 English
Conditional Placing to raise £1.75 million
Capital/Financing Update Classification · 95% confidence The document is an official announcement released via RNS (RNS Number: 5566J) on April 27, 2022. The content details several corporate actions simultaneously: a Conditional Placing to raise £1.75 million, the Publication of a Prospectus, a Proposed Waiver of Rule 9 of the Takeover Code, and a Notice of General Meeting. Since the document announces the publication of a Prospectus and a Circular (which contains the Notice of General Meeting) and details significant capital raising and corporate governance actions related to an acquisition, it is a comprehensive regulatory disclosure. Given the focus on fundraising (Placing) and the associated corporate governance/shareholder approval requirements (General Meeting, Rule 9 Waiver), it strongly relates to financing activities. However, the document explicitly announces the 'Publication of Prospectus' and the 'Publication and despatch of Circular' (which contains the General Meeting notice). Because it is a formal announcement detailing multiple significant corporate events, including the issuance of new shares and warrants, it fits best under Capital/Financing Update (CAP) or a general Regulatory Filing (RNS). Since it is primarily focused on raising capital (£1.75 million Placing) and the associated legal/governance steps (Prospectus, GM), 'CAP' is highly relevant. However, the document structure is typical of a broad regulatory announcement that covers multiple topics, including capital changes and governance votes. Given the explicit mention of 'Publication of Prospectus' and the nature of the announcement being a primary regulatory release covering financing, governance, and a major acquisition context, it is a strong candidate for a Capital/Financing Update (CAP) or a general Regulatory Filing (RNS). Since the core driver is the conditional placing and the associated capital structure changes, CAP is the most specific fit among the financial action codes. If it were purely announcing the availability of a report without substantive content, RPA/RNS would be chosen, but this document contains the substance of the financing deal itself.
2022-04-27 English
Full accounts made up to 2021-09-30
Regulatory Filings
2022-02-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.